Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-23
ADCOCK INGRAM
Jun-14
ALEMBIC PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs792320-   
Low Rs463231-   
Sales per share (Unadj.) Rs287.695.1-  
Earnings per share (Unadj.) Rs17.4-24.0-  
Cash flow per share (Unadj.) Rs31.4-19.9-  
Dividends per share (Unadj.) Rs8.000-  
Avg Dividend yield %1.30-  
Book value per share (Unadj.) Rs222.374.6-  
Shares outstanding (eoy) m196.56168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.22.9 75.5%   
Avg P/E ratio x36.1-11.5 -314.2%  
P/CF ratio (eoy) x20.0-13.9 -144.2%  
Price / Book Value ratio x2.83.7 76.6%  
Dividend payout %46.00-   
Avg Mkt Cap Rs m123,40246,446 265.7%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m11,6912,915 401.1%   
Avg. sales/employee Rs Th03,739.2-  
Avg. wages/employee Rs Th0679.0-  
Avg. net profit/employee Rs Th0-942.2-  
INCOME DATA
Net Sales Rs m56,52616,052 352.1%  
Other income Rs m30112 27.0%   
Total revenues Rs m56,55716,165 349.9%   
Gross profit Rs m6,772-2,782 -243.4%  
Depreciation Rs m2,754693 397.6%   
Interest Rs m502435 115.4%   
Profit before tax Rs m3,546-3,797 -93.4%   
Minority Interest Rs m0-11 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m126237 53.1%   
Profit after tax Rs m3,420-4,045 -84.5%  
Gross profit margin %12.0-17.3 -69.1%  
Effective tax rate %3.6-6.2 -56.9%   
Net profit margin %6.1-25.2 -24.0%  
BALANCE SHEET DATA
Current assets Rs m29,13911,757 247.8%   
Current liabilities Rs m16,4086,615 248.0%   
Net working cap to sales %22.532.0 70.3%  
Current ratio x1.81.8 99.9%  
Inventory Days Days10111 8.7%  
Debtors Days Days7124 5.5%  
Net fixed assets Rs m31,4986,853 459.6%   
Share capital Rs m39375 527.4%   
"Free" reserves Rs m43,3120-   
Net worth Rs m43,70512,599 346.9%   
Long term debt Rs m04,428 0.0%   
Total assets Rs m60,63723,801 254.8%  
Interest coverage x8.1-7.7 -104.3%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.90.7 138.2%   
Return on assets %6.5-15.2 -42.6%  
Return on equity %7.8-32.1 -24.4%  
Return on capital %9.3-19.8 -46.8%  
Exports to sales %46.40-   
Imports to sales %12.10-   
Net fx Rs m19,3640-   
CASH FLOW
From Operations Rs m7,2401,370 528.4%  
From Investments Rs m-4,476-421 1,063.9%  
From Financial Activity Rs m-2,6204,018 -65.2%  
Net Cashflow Rs m1444,968 2.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.41 Rs / ZAR

Compare ALEMBIC PHARMA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare ALEMBIC PHARMA With: ZENITH HEALTH  SOLARA ACTIVE PHARMA SCIENCES  ORCHID PHARMA  TTK HEALTHCARE  AAREY DRUGS  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.